Welcome to MyStrategist, the digital home for MedTech Strategist.

MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today

Browse   Latest Issue
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.


Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.


Business Strategies

Personalized Medicine is Coming to Chronic Low Back Pain

Low back pain, one of the most prevalent chronic conditions, is in the early stages of moving toward a more stratified, personalized model of care. Large spine companies remain focused on their core, one-size-fits-all businesses, while advances in scientific understanding of pain and technology are creating opportunities for new entrants like Aclarion, Persica Pharma, and Boston Scientific. A first of its kind, the NIH Heal Initiative has laid the groundwork, even as it weathers funding cuts

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.


Start-Ups

Levron Cardiovascular Harnesses the Body’s Own Mechanism to Relieve Heart Failure

Addressing heart failure, Levron Cardiovascular synchronizes the body's "respiratory" pump with the heart beat, to shift fluid out of the lungs and boost outflow from the left ventricle. In essence, the concept turns a physiological interaction that normally exists in the body into a therapeutic advantage. A companion article to "Innovating Heart Failure: Start-Ups Harness Natural Pathways."

Discover the opportunities and challenges that impact the global medtech regulatory and reimbursement community with Market Pathways.

Subscribe   Free Premier Issue   Learn More